Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Adjuvant for Femoral Nerve Block in Hip Fracture
NCT02248870Phase 4Terminated
- Sponsor
- Aarhus University
- Start
- Mar 2015
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in hip fracture (2 arms), sponsored by Aarhus University. Primary endpoint: Frequency of analgesia at the time of operation or at 20 hours. Started Mar 2015; status: terminated.
02
Drugs
dexamethasone
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT02248870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02248870.